Webinar | Human Immune Profiling Simplified

June 13, 2019 | 9 am PT, 12 pm ET

30 Markers. 1 Tube. 5-Minute Data Analysis.

Save your Spot

Thursday, June 13, 2019
9:00 am PT, 12:00 pm ET, 4:00pm GMT


Immune profiling of PBMC and peripheral whole blood is an essential method for quantifying changes in immune cell populations in autoimmune disease, chronic inflammation, infectious disease and cancer.

In this webinar, Michelle Poulin, Manager, Field Applications, will introduce an innovative mass cytometry application, the Maxpar® Direct™ Immune Profiling System, which provides a complete sample-to-answer solution for high-parameter immune monitoring.

The system combines

  • CyTOF® technology on the Helios™ system
  • a dry, single-tube 30-marker antibody panel
  • automated Maxpar Pathsetter™ software

and enables enumeration of 37 immune cell populations from PBMC and whole blood in as little as 5 minutes. The system is also flexible, allowing for addition of antibodies and development of new analysis models.

Thiru Selvanantham, Senior Product Applications Scientist, will present data on repeatability, precision and accuracy, as well as site-to-site reproducibility from external multisite testing of the system.

Who should attend:

  • Core facility directors and research investigators engaged in immune monitoring studies
  • Researchers in immuno-oncology, autoimmune disease, infectious disease or allergy
  • Anyone interested in learning more about mass cytometry

Can’t attend the live webinar? Register anyway and receive a link to the recording!

Thursday, June 13, 2019
9:00 am PT, 12:00 pm ET, 4:00 pm GMT


Michelle Poulin Michelle Poulin, PhD
Manager, Field Applications

Michelle Poulin earned her bachelor’s degree from Smith College and her PhD in immunology from the University of Colorado, Denver. After completing a post-doctoral fellowship at National Jewish Health in 2003, she joined BD Biosciences as an instructor in the Customer Education Department. In 2012, Poulin joined DVS Sciences as a field applications scientist. She became Manager of the North American Field Applications Scientist Team shortly after DVS was acquired by Fluidigm in 2014.

Thiru Selvanantham Thiru Selvanantham, PhD
Senior Product Applications Scientist

Thiru Selvanantham earned her PhD in immunology from the University of Toronto, with a focus on invariant natural killer T (iNKT) cell activation by bacterial products. For more than two years she has worked as an applications scientist at Fluidigm. She is involved in customer support and new product development, including the Maxpar Direct Immune Profiling Assay™.

Fluidigm Products are for Research Use Only. Not for use in diagnostic procedures.